0 Bewertungen0% fanden dieses Dokument nützlich (0 Abstimmungen)
365 Ansichten2 Seiten
Acetaminophen is a nonopioid analgesic that may block pain may be chewed. Hepatotoxicity, hepatic seizure give with food or milk to decrease gastric symptoms; peripherally that GI: NV, abdominal pain; give 30 min before or 2 hr after meals, absorption may occur in response (overdose) GI bleeding be slowed; Assess for fever and pain: type, location, possess antiintensity,
Acetaminophen is a nonopioid analgesic that may block pain may be chewed. Hepatotoxicity, hepatic seizure give with food or milk to decrease gastric symptoms; peripherally that GI: NV, abdominal pain; give 30 min before or 2 hr after meals, absorption may occur in response (overdose) GI bleeding be slowed; Assess for fever and pain: type, location, possess antiintensity,
Acetaminophen is a nonopioid analgesic that may block pain may be chewed. Hepatotoxicity, hepatic seizure give with food or milk to decrease gastric symptoms; peripherally that GI: NV, abdominal pain; give 30 min before or 2 hr after meals, absorption may occur in response (overdose) GI bleeding be slowed; Assess for fever and pain: type, location, possess antiintensity,
Medication Worksheet Student Name: Millie Hearon Generic: acetaminophen Classification: Functional: Nonopioid analgesic Trade: Tylenol Chemical: Nonsalicylate, paraaminophenol derivative Mechanism of Adverse Side Effects: Nursing Considerations: Action: Administration: CNS: Stimulation, drowsiness Administer to patient crushed or whole, chewable tabs May block pain may be chewed; do not crush or chew ER product. impulses GI: NV, abdominal pain; Give with food or milk to decrease gastric symptoms; peripherally that hepatotoxicity, hepatic seizure give 30 min before or 2 hr after meals, absorption may occur in response (overdose) GI bleeding be slowed. to inhibition of prostaglandin GU: Renal failure (high, prolonged Assessment: synthesis; does not dose) Assess for fever and pain: type of pain, location, possess antiintensity, duration, temp, and diaphoresis. Assess for inflammatory HEMA: Thrombocytopenia, chronic poisoning: rapid, weak pulse; dyspnea; cold, properties; leucopenia, neutropenia, hemolytic clammy extremities; report immediately to prescriber. antipyretic action anemia, pancytopenia Assess for hepatotoxicity: dark urine, clay-colored results from stools, yellowing of skin and sclera; itching, abdominal inhibition of INTEG: Rash, urticaria pain, fever, and diarrhea if patient is on long-term prostaglandins in therapy. Assess for allergic reactions: if rash, urticaria the CNS SYST: Hypersensitivity occur, product may have to be discontinued Monitor: TOXICITY: Cyanosis, anemia, Monitor LFT: AST, ALT, bilirubin, creatinine before Black Box neutropenia, jaundice, therapy if long-term therapy in anticipated; may cause Warning: pancytopenia, CNS stimulation, hepatic toxicity at doses >4g/day with chronic use. delirium followed by vascular Monitor renal function studies: BUN, urine, creatinine, OB Warning: collapse, seizures, coma, death, occult blood; albumin indicates nephritis. Monitor Category B hepatic damage. blood studies: CBC, PT if patient is on long-term therapy. Check I&O ratio; decreasing output may indicate renal failure Pediatric Safe Dose: Education: (Nurs 245 Only) Teach patient not to exceed recommended dosage;
Clinical Date:
Name of Medication: Trade:
(Skidmore-Roth, 2014)
Dosage/Route and Time:
acute poisoning with liver damage may result; acute
toxicity includes symptoms of nausea, vomiting, and abdominal pain; prescriber should be notified immediately. Do not use with combination products. Do not use alcohol without prescriber approval. Recognize symptoms of chronic overdose: bleeding, bruising, malaise, fever, and sore throat. Urine may become dark brown as result of phenacetin. Tell patient to notify prescriber for pain or fever lasting more than 3 days. Reason YOUR patient is Adverse reactions receiving medication: specific to this med